The iManageCancer platform
6 Aug 2018
The iManageCancer platform
The ICMC: a new path for microbiome research
The microbiome and cancer: cause or correlation?
Future EU framework programmes
IG rearrangement, JAK1/2 inhibition and aggressive B-cell lymphoma development...
The breakthrough drug designation, patients driving progress
Beyond standard of care: the next steps of Precision Oncology
The TAPUR trial family: a global data sharing platform
The 10th Anniversary of the WIN Consortium: lessons and perspectives
Biobanking and early diagnosis to defeat NSCLC
Early development in oncology: Are the MTD and monotherapy efficacy still the best objectives?
U.S. National Cancer Institute perspective on precision oncology